Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 29 | 4 | 7 | 13 | 0 |
| Cost of Goods | 3 | 4 | 8 | 4 | 0 |
| Gross Profit | 26 | 1 | -1 | 9 | N/A |
| Operating Expenses | 17 | 27 | 21 | 16 | 0 |
| Operating Income | 12 | -23 | -14 | -3 | 0 |
| Pre-tax Income | 12 | -23 | -14 | -3 | 0 |
| Income Tax | 3 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 9 | -23 | -14 | -3 | 0 |
| Net Income | $9 | $-23 | $-14 | $-3 | $0 |
| EPS Basic Total Ops | 0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $12 | $-23 | $-14 | $-3 | $0 |